This content is machine translated Interview at ASCO GI on new data from the OPUS study. “We are a good step closer to personalized therapy in mCRC” In the treatment of metastatic colorectal cancer, there were new results on subgroup analyses of the OPUS trial at this year’s ASCO GI in San Francisco. As previously shown in…
View Post 4 min This content is machine translated Metastatic colorectal carcinoma To what extent does aspirin affect survival? More recently, studies have shown that aspirin improves overall survival in subgroups with colorectal cancer, specifically those with PIK3CA mutations. To test whether regular aspirin use is associated with survival…
View Post 5 min This content is machine translated Pancreatic adenocarcinoma The “borderline resectable” tumors as a specific challenge. At ASCO-GI in San Francisco, one of the topics was pancreatic adenocarcinoma. The so-called “borderline resectable” tumors were of particular interest. It is up for discussion whether primary surgery is…
View Post 4 min This content is machine translated Treatment of metastatic colorectal carcinoma. Patients with RAS wild type benefit in overall survival New data on first-line treatment of metastatic colorectal cancer were presented at the ASCO GI in San Francisco. The post-hoc analyses consistently confirm that RAS mutation status is an important…
